Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology | Hematology

Acute Myelogenous Leukemia (AML)

Arizona

Peoria : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

California

Duarte : City of Hope

CIBMRT 05-DCB: A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation (UCBT) in Adults with Hematologic Malignancy

Duarte : City of Hope

PHII-86 NCI #7925: A Phase 2 Study of AZD6244 in Relapsed or Refractory AML

Duarte : City of Hope

SWOG 9007: Cytogenetic Studies In Leukemia Patients

Los Angeles : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Colorado

Denver : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Florida

Hialeah : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Illinois

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Chicago : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Hines : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Indiana

Beech Grove : St. Francis Hospital and Health Centers

Phase IIB, Multicenter, Randomized, Open-Label Trial Of CPX-351 (Cytarabine : Daunorubicin) Liposome Injection Versus Intensive Salvage Therapy In Adult Patients = 60 Years Old With AML In First Relapse Following An Initial CR > 1 Month Duration

Beech Grove : St. Francis Hospital and Health Centers

SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717)

Beech Grove : St. Francis Hospital and Health Centers

Study of SNS-595 in Older Patients With Untreated Acute Myeloid Leukemia

Beech Grove : St. Francis Hospital and Health Centers

Trial of CPX-351 in Newly Diagnosed Edlerly AML Patients

Missouri

Saint Louis : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New Jersey

Newark : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

New York

East Syracuse : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Lake Success : Biomedical Research Alliance of New York

Acute Myelogenous Leukemia (AML) - Adults

Lake Success : Biomedical Research Alliance of New York

Untreated AML (AML is a fast growing cancer that starts inside bone marrow, the soft tissue inside bones that helps form blood cells ) - Adults

Rochester : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Rhode Island

Providence : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Texas

Houston : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Virginia

Charlottesville : University of Virginia New!

Children, Adolescents, and Young Adults with Acute Myeloid Leukemia (AML) Sought for Research Study

Washington

Seattle : Merck

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals

Australia

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

Clinical trial of an investigational vaccine for the prevention of shingles and shingles-related complications in immunocompromised individuals


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.